BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Krasimirova E, Velikova T, Ivanova-Todorova E, Tumangelova-Yuzeir K, Kalinova D, Boyadzhieva V, Stoilov N, Yoneva T, Rashkov R, Kyurkchiev D. Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients. World J Exp Med 2017; 7(3): 84-96 [PMID: 28890870 DOI: 10.5493/wjem.v7.i3.84]
URL: https://www.wjgnet.com/1948-0210/full/v7/i3/84.htm
Number Citing Articles
1
Sambhawana Bhandari, Sadikshya Bhandari, Samikshya Bhandari. Chimeric antigen receptor T cell therapy for the treatment of systemic rheumatic diseases: a comprehensive review of recent literatureAnnals of Medicine & Surgery 2023; 85(7): 3512 doi: 10.1097/MS9.0000000000000891
2
Tianlu Li, Lourdes Ortiz-Fernández, Eduardo Andrés-León, Laura Ciudad, Biola M. Javierre, Elena López-Isac, Alfredo Guillén-Del-Castillo, Carmen Pilar Simeón-Aznar, Esteban Ballestar, Javier Martin. Epigenomics and transcriptomics of systemic sclerosis CD4+ T cells reveal long-range dysregulation of key inflammatory pathways mediated by disease-associated susceptibility lociGenome Medicine 2020; 12(1) doi: 10.1186/s13073-020-00779-6
3
Lazaros I. Sakkas, Theodora Simopoulou. Translational Autoimmunity2023; : 447 doi: 10.1016/B978-0-323-85831-1.00022-X
4
Ann‐Helen Rosendahl, Katrin Schönborn, Thomas Krieg. Pathophysiology of systemic sclerosis (scleroderma)The Kaohsiung Journal of Medical Sciences 2022; 38(3): 187 doi: 10.1002/kjm2.12505
5
Miyu Kano, Tadahiro Kobayashi, Mutsumi Date, Momoko Tennichi, Yasuhito Hamaguchi, Daniel S Strasser, Kazuhiko Takehara, Takashi Matsushita. Attenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimodScientific Reports 2019; 9(1) doi: 10.1038/s41598-018-37074-9
6
Jie Pan, Fei Dong, Li Ma, Cheng Zhao, Fang Qin, Jing Wen, Wanling Wei, Ling Lei. Therapeutic effects of thalidomide on patients with systemic sclerosis-associated interstitial lung diseaseJournal of Scleroderma and Related Disorders 2023; 8(3): 231 doi: 10.1177/23971983231180077
7
Yi Lu, Cheng Zhao, Ling Lei, Zhiqing Tao, Leting Zheng, Jing Wen, Xi Li. Effects of thalidomide on Th17, Treg cells and TGF‐β1/Smad3 pathway in a mouse model of systemic sclerosisInternational Journal of Rheumatic Diseases 2020; 23(3): 406 doi: 10.1111/1756-185X.13769
8
Zhen Yu, Hao Cheng, Tingting Ding, Yuying Liang, Chenglan Yan, Chong Gao, Hongyan Wen. Absolute decrease in regulatory T cells and low-dose interleukin-2 therapy: restoring and expanding regulatory T cells to treat systemic sclerosis: a 24-week studyClinical and Experimental Dermatology 2022; 47(12): 2188 doi: 10.1111/ced.15345
9
Satomi Kobayashi, Yasuo Nagafuchi, Hirofumi Shoda, Keishi Fujio. The Pathophysiological Roles of Regulatory T Cells in the Early Phase of Systemic SclerosisFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.900638
10
Jialing Wu, Xi Zhang, Shen Lin, Qiujing Wei, Zhiming Lin, Ou Jin, Jieruo Gu. Alterations in peripheral T‐ and B‐cell subsets in patients with systemic sclerosisInternational Journal of Rheumatic Diseases 2024; 27(4) doi: 10.1111/1756-185X.15145
11
T. Velikova, S. Lazova, P. Perenovska, K. Tumangelova-Yuzeir, D. Miteva, P. Velikov, E. Ivanova-Todorova, D. Kyurkchiev, G. Petrova. Th17 cells in Bulgarian children with chronic obstructive lung diseasesAllergologia et Immunopathologia 2019; 47(3): 227 doi: 10.1016/j.aller.2018.07.004
12
Qiao Wang, Guoshan Shi, Yun Zhang, Feilong Lu, Duoli Xie, Chengping Wen, Lin Huang. Deciphering the Potential Pharmaceutical Mechanism of GUI-ZHI-FU-LING-WAN on Systemic Sclerosis based on Systems Biology ApproachesScientific Reports 2019; 9(1) doi: 10.1038/s41598-018-36314-2
13
Anouk C. M. Platteel, Bob Meek, Anja Roos. Introductie in de immunologieBijblijven 2018; 34(2): 84 doi: 10.1007/s12414-018-0293-7
14
Maria-Cristina Arcangeletti, Clara Maccari, Rosanna Vescovini, Riccardo Volpi, Dilia Giuggioli, Gianluca Sighinolfi, Flora De Conto, Carlo Chezzi, Adriana Calderaro, Clodoveo Ferri. A Paradigmatic Interplay between Human Cytomegalovirus and Host Immune System: Possible Involvement of Viral Antigen-Driven CD8+ T Cell Responses in Systemic SclerosisViruses 2018; 10(9): 508 doi: 10.3390/v10090508
15
M Brown, S O’Reilly. The immunopathogenesis of fibrosis in systemic sclerosisClinical and Experimental Immunology 2019; 195(3): 310 doi: 10.1111/cei.13238
16
Se Yun Cheon, Jong Ho Park, Amir H. Ameri, Richard T. Lee, Rosalynn M. Nazarian, Shadmehr Demehri. IL-33/Regulatory T-Cell Axis Suppresses Skin FibrosisJournal of Investigative Dermatology 2022; 142(10): 2668 doi: 10.1016/j.jid.2022.03.009
17
Xinjuan Liu, Yu Wu, Mengtao Li, Jianyu Hao, Qian Wang, Xiaofeng Zeng. Plasticity of Treg and imbalance of Treg/Th17 cells in patients with systemic sclerosis modified by FK506International Journal of Immunopathology and Pharmacology 2021; 35: 205873842199808 doi: 10.1177/2058738421998086
18
Inês S. Silva, Beatriz H. Ferreira, Catarina R. Almeida. Molecular Mechanisms Behind the Role of Plasmacytoid Dendritic Cells in Systemic SclerosisBiology 2023; 12(2): 285 doi: 10.3390/biology12020285
19
Nicole Chizara Oparaugo, Kelsey Ouyang, Nam Phuong N. Nguyen, Amanda M. Nelson, George W. Agak. Human Regulatory T Cells: Understanding the Role of Tregs in Select Autoimmune Skin Diseases and Post-Transplant Nonmelanoma Skin CancersInternational Journal of Molecular Sciences 2023; 24(2): 1527 doi: 10.3390/ijms24021527
20
Stefania Nicola, Giovanni Rolla, Caterina Bucca, Giada Geronazzo, Irene Ridolfi, Andrea Ferraris, Enrico Fusaro, Clara Lisa Peroni, Luca Dughera, Luisa Brussino. Gastric Juice Expression of Th-17 and T-Reg Related Cytokines in Scleroderma Esophageal InvolvementCells 2020; 9(9): 2106 doi: 10.3390/cells9092106
21
Jeffrey C. Y. Yu, Yixiao Zeng, Kaiqiong Zhao, Tianyuan Lu, Kathleen Oros Klein, Inés Colmegna, Maximilien Lora, Sahir R. Bhatnagar, Andrew Leask, Celia M. T. Greenwood, Marie Hudson. Novel insights into systemic sclerosis using a sensitive computational method to analyze whole-genome bisulfite sequencing dataClinical Epigenetics 2023; 15(1) doi: 10.1186/s13148-023-01513-w
22
Fengyi Xiao, Xishi Liu, Sun-Wei Guo. Platelets and Regulatory T Cells May Induce a Type 2 Immunity That Is Conducive to the Progression and Fibrogenesis of EndometriosisFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.610963
23
Wei Jin, Yan Zheng, Ping Zhu. T cell abnormalities in systemic sclerosisAutoimmunity Reviews 2022; 21(11): 103185 doi: 10.1016/j.autrev.2022.103185
24
Camelia Frantz, Cedric Auffray, Jerome Avouac, Yannick Allanore. Regulatory T Cells in Systemic SclerosisFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02356
25
Lisa Göschl, Clemens Scheinecker, Michael Bonelli. Treg cells in autoimmunity: from identification to Treg-based therapiesSeminars in Immunopathology 2019; 41(3): 301 doi: 10.1007/s00281-019-00741-8
26
Di Wang, Ling Lei. Interleukin‐35 regulates the balance of Th17 and Treg responses during the pathogenesis of connective tissue diseasesInternational Journal of Rheumatic Diseases 2021; 24(1): 21 doi: 10.1111/1756-185X.13962
27
Junsuk Ko, Maria Noviani, Vasuki Ranjani Chellamuthu, Salvatore Albani, Andrea Hsiu Ling Low. The Pathogenesis of Systemic Sclerosis: The Origin of Fibrosis and Interlink with Vasculopathy and AutoimmunityInternational Journal of Molecular Sciences 2023; 24(18): 14287 doi: 10.3390/ijms241814287
28
Steven O’Reilly. Emerging therapeutic targets in systemic sclerosisJournal of Molecular Medicine 2024; 102(4): 465 doi: 10.1007/s00109-024-02424-w